A RT-qPCR based method for the determination of Programmed death-ligand 1 (PD-L1) mRNA expression. The kit can be applied on RNA samples extracted from Circulating Tumor Cells (CTCs) of NSCLC, HNSCC and melanoma cancer patients.

The Oncolipsy PD-L1 Kit offers:

  • Reliable determination of PD-L1 mRNA expression
  • High sensitivity
  • Simple set-up and interpretation
  • Ready-to-use and stable master-mixes
  • Results in less than 3 hours from cDNA synthesis step